Disseminated Mucormycosis Due to Cunninghamella Bertholletiae in a Liver Transplant Recipient

Total Page:16

File Type:pdf, Size:1020Kb

Disseminated Mucormycosis Due to Cunninghamella Bertholletiae in a Liver Transplant Recipient Postgraduate Medical Journal (1988) 64, 82-84 Postgrad Med J: first published as 10.1136/pgmj.64.747.82 on 1 January 1988. Downloaded from Disseminated mucormycosis due to Cunninghamella bertholletiae in a liver transplant recipient G.R. Nimmo, R.F. Whiting and R.W. Strong Departments of Clinical Microbiology, Intensive Care and Surgery, Princess Alexandra Hospital, Brisbane, Australia. Summary: Disseminated mucormycosis occurred in a 19 year old female following orthotopic liver transplantation for fulminant Wilson's disease. The causative organism Cunninghamella bertholletiae has previously been described in ten clinical cases, but never before in this setting. Introduction Mucormycosis is a recognized complication in due mainly to the severe coagulopathy and portal patients who are acidotic or who have hypertension. compromised cellular immune defences due to At operation the patient had 3 litres of ascites, a primary disease or immunosuppressive therapy. It is nodular liver weighing 1810 grams and evidence of being increasingly described as an infective severe portal hypertension with numerous varices. complication of organ transplantation.'12 At the Histology of the removed liver showed micro- same time species only rarely identified as causal nodular cirrhosis. The hepatic copper content was agents in the past are being reported with greater 28,200 mol/kg dry weight (normal range 400-1700)copyright. frequency.1 This report of a case of disseminated confirming the diagnosis of Wilson's disease. infection due to Cunninghamella bertholletiae is the Immunosuppressive therapy consisted of cyclo- first reported in a liver transplant and illustrates the sporin A 4mg/kg/day intravenously and methyl- difficulties encountered in the diagnosis and prednisolone 50mg four times daily intravenously, treatment of this condition. reducing to 20mg four times daily by 16th post- operative day. The post-operative course was Case report complicated by oliguric renal failure which responded to fluids, low dose dopamine and A 19 year old female was admitted deeply frusemide. Bile production by the transplanted liver http://pmj.bmj.com/ jaundiced and encephalopathic. She had a two week was poor but liver enzymes and prothrombin time history of upper abdominal pain, progressive returned to normal limits by the end of the first anaemia and deepening jaundice. A diagnosis of week. fulminant Wilson's disease was made and it was Chest radiographs initially showed bilateral decided that liver transplantation was the only pulmonary oedema. This had largely cleared by the potentially effective method of treatment. Major third day leaving a residual area of consolidation at the right lung base. Diagnoses considered included clinical problems were acute hepatic failure with on October 2, 2021 by guest. Protected encephalopathy, severe coagulopathy, severe intra- infection, aspiration and septic embolism. Sputum vascular haemolysis and impending renal failure. microscopy revealed Gram negative rods and Gram She was treated with charcoal haemoperfusion, positive cocci. The leukocyte count was at the blood and component therapy and on the fourth upper limit of normal with a relative neutrophilia. day following admission underwent orthotopic liver The patient was afebrile and was begun on transplantation. The procedure took 13 hours to tobramycin 200mg twice daily and flucloxacillin 1 g perform and blood loss was approximately 51 units six hourly. Some clearing of the consolidation was noted on the following day's radiograph. Sputum Correspondence: G.R. Nimmo, M.B., B.S., M.Sc., culture grew a heavy growth of Enterobacter sp. F.R.C.P.A., Department of Clinical Microbiology, and scanty Streptococcus faecalis. Princess Alexandra Hospital, Woolloongabba 4102, Both hepatic function and the patient's general Australia condition showed a definite improvement by day 6 Accepted: 8 July 1987 and an unsuccessful attempt to wean her from © The Fellowship of Postgraduate Medicine, 1988 CLINICAL REPORTS. 83 Postgrad Med J: first published as 10.1136/pgmj.64.747.82 on 1 January 1988. Downloaded from mechanical ventilation was made on day 7. She Mucorales of the class Zygomycotina. It is became febrile on the following day and chest characterized by rapid tissue spread with vascular radiographs showed worsening of consolidation at invasion. The mode of infection would appear to be the right lung base and new consolidation at the by inhalation of spores in the case of the rhino- left base. Amoxicillin 1g four hourly and metro- cerebral and pulmonary forms, while direct nidazole 500mg eight hourly were added to her inoculation is thought to account for primary therapy. Aspergillus fumigatus was isolated from a subcutaneous infections. In vitro studies by Waldorf sputum culture taken on day 9 and amphotericin B and co-workers3 have shown that defective broncho- was commenced as fungal infection was considered alveolar macrophage function allows spore probable. germination to occur in diabetic and cortisone An open lung biopsy was performed on day 11. treated mice. Dissemination from a primary The biopsy consisted of a wedge of the left lower pulmonary focus is not uncommon. lobe as the advent of consolidation in this area had Infection due to organisms of the genus Cunning- coincided with the onset of fever and general hamella is uncommon and only ten cases have been deterioration. Stains and cultures were performed previously reported.5 6 Pulmonary involvement was to exclude Pneumocystis carinii, fungi, noted in six cases, of which four had disseminated mycobacteria, Legionella sp. and other bacteria and disease. All the patients had an underlying disease all proved negative. The histological appearance likely to compromise immune defences and seven was consistent with adult respiratory distress had received steroid therapy. Our case certainly syndrome and, although no specific cause was conforms to this pattern. It is, however, the first obvious, aspiration was felt to be a likely case reported in a liver transplant recipient and antecedent. only the second case of mucormycosis in this The patient remained febrile and antifungal setting. The previous case would appear to have therapy was ceased while antibacterial therapy was been diagnosed histologically as no mycological continued with the substitution of vancomycin for details were recorded.7 flucloxacillin. After some initial clearing of In the past there has been some confusion in the consolidation on day 12, radiographic appearances literature regarding the classification of clinical continued to worsen as did her general clinical state isolates of Cunninghamella. In their study of the copyright. until the patient died on day 17 post-transplant. mating behaviour of Cunninghamella spp., At autopsy fungal infection was found in all Weitzman and Crist established that Cunninghamella lobes of both lungs, with dissemination to the bertholletiae, and not Cunninghamella elegans, is the mediastinum, left ventricle, brain, thymus and species causing human infection.8 In their thyroid. The histological appearance was of broad subsequent physiological and morphological studies hyphae with relatively few septae and haphazard thermotolerance proved to be the key differential branching. Fungal invasion of vessel walls was a feature.9 Cunninghamella elegans does not grow at noticeable feature. Multiple post-mortem specimens 400C. from the lungs and mediastinum grew a grey-white The difficulty of ante-mortem diagnosis of http://pmj.bmj.com/ cotton wool-like fungus. Growth was evident at 24 mucormycosis has been noted previously.10 Five of hours on Sabouraud dextrose agar incubated at the ten cases of Cunninghamella infection in the 25°C and 37°C and was luxuriant after 72 hours. literature were diagnosed post-mortem. Biopsy of On subculture, growth also occurred at 42°C but involved tissue would appear to be the most was less marked. Hyphae of 7 to 11 im diameter promising diagnostic approach although it was were smooth and hyaline with infrequent septae unsuccessful in this case. The area of the left lobe and branched at acute and right angles. selected for biopsy had shown the most recent on October 2, 2021 by guest. Protected Sporangiophores were vertical with globose to radiological changes, the advent of which had subglobose terminal vesicles bearing spinelike coincided with clinical deterioration. It is phialides. Conidia were spherical to ellipsoidal and disappointing that the tissue biopsied was not measured 7 to 14 tm. Based on these criteria the representative of the infectious process which must fungus was identified as Cunninghamella have been active at the time. Realising the obvious bertholletiae, a zygomycete of the order Mucorales. difficulties encountered in the timely diagnosis of this condition using current techniques, it would seem that alternative strategies may be needed. Discussion Serological diagnosis of the infections warrants further investigation. Yankey & Abraham have Mucormycosis is an acute opportunistic mycosis demonstrated high levels of specific IgA and IgM caused by thermotolerant genera of the order by immunofluorescence in a patient with cranio- 84 CLINICAL REPORTS Postgrad Med J: first published as 10.1136/pgmj.64.747.82 on 1 January 1988. Downloaded from facial mucormycosis." The antigenic profiles of number of cases recorded. Only two patients have some potentially pathogenic mucoraceous fungi survived so far, but it is worth noting that only have been compared by Hessian & Smith12
Recommended publications
  • Mals (22,24,28,31,32)
    Brazilian Journal of Microbiology (2003) 34:363-372 ISSN 1517-8382 EFFECTS OF PHOSPHORUS ON POLYPHOSPHATE ACCUMULATION BY CUNNINGHAMELLA ELEGANS Marcos Antonio Barbosa de Lima1,2,3; Aline Elesbão do Nascimento1,2; Wanderley de Souza4; Kazutaka Fukushima 5; Galba Maria de Campos-Takaki 1,2,3* 1Núcleo de Pesquisas em Ciências Ambientais; Departamentos de Biologia e Química, Universidade Católica de Pernambuco, Recife, PE, Brasil. 2Laboratório de Imunopatologia Keizo Asami, Microscopia Eletrônica, Universidade Federal de Pernambuco, Recife, PE, Brasil. 3Centro de Ciências Biológicas, Departamento de Micologia, Mestrado em Biologia de Fungos, Universidade Federal de Pernambuco, Recife, PE, Brasil. 4Instituto de Biofísica Carlos Chagas Filho, Laboratório de Ultraestrutura Celular, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil. 5Research Center for Pathogenic Fungi and Microbial Toxicosis, Chiba University, Chiba, Japan. Submitted: February 02, 2003; Returned to Authors for corrections: April, 29, 2003; Approved: July 08, 2003 ABSTRACT The content of inorganic polyphosphate and the polymeric degree of these compounds were evaluated during the growth of Cunninghamella elegans in medium containing varying orthophosphate (Pi) concentrations. For this purpose, a combination of chemical methods for polyphosphate extraction and ultrastructural cytochemistry were used. The orthophosphate and glucose consumption was also determined during the fungal cultivation. At Pi concentrations of 0.5, 2.5 and 0.0 g/L, the maximum amounts of biomass were 3.18, 3.29 and 0.24 g/L, respectively. During growth the cells accumulated Pi from the medium. At three days of growth the biomass consumed up to 100 and 95% of Pi from the media at initial concentrations of 0.5 and 2.5 g/L, respectively.
    [Show full text]
  • VU Research Portal
    VU Research Portal Yeast as a model eukaryote in drug safety studies van Leeuwen, J.S. 2011 document version Publisher's PDF, also known as Version of record Link to publication in VU Research Portal citation for published version (APA) van Leeuwen, J. S. (2011). Yeast as a model eukaryote in drug safety studies: New insights on diclofenac- induced toxicity. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. E-mail address: [email protected] Download date: 02. Oct. 2021 I Yeast as a model organism for biotransformation- related toxicity 7 Chapter 1 OUTLINE High drug attrition rates due to toxicity, the controversy of experimental animal usage, and the EU REACH regulation demanding toxicity profiles of a high number of chemicals demonstrate the need for new, in vitro toxicity models with high predictivity and throughput. Metabolism by cytochrome P450s is one of the main causes of drug toxicity.
    [Show full text]
  • Cunninghamella As a Microbiological Model for Metabolism of Histamine H3 Receptor Antagonist 1-[3-(4-Tert-Butylphenoxy)Propyl]Piperidine
    Appl Biochem Biotechnol (2012) 168:1584–1593 DOI 10.1007/s12010-012-9880-8 Cunninghamella as a Microbiological Model for Metabolism of Histamine H3 Receptor Antagonist 1-[3-(4-tert-Butylphenoxy)propyl]piperidine Elżbieta Pękala & Paulina Kubowicz & Dorota Łażewska Received: 5 March 2012 /Accepted: 28 August 2012 / Published online: 16 September 2012 # The Author(s) 2012. This article is published with open access at Springerlink.com Abstract The aim of the study was to analyze the ability of the microorganism Cunninghamella to carry out the biotransformation of 1-[3-(4-tert-butylphenoxy)- propyl]piperidine (DL76) and to compare the obtained results with in silico models. Biotransformation was carried out by three strains of filamentous fungus: Cunning- hamella echinulata, Cunninghamella blakesleeana,andCunninghamella elegans. Most probable direction of DL76 metabolic transition was the oxidation of the methyl group in the tert-butyl moiety leading to the formation of the metabolite with I° alcohol properties. This kind of reaction was conducted by all three strains tested. However, only in the case of C. blakesleeana that biotransformation product had a structure of carboxylic acid. CYP2C19 was identified by Metasite software to be the isoform of major importance in the oxidation process in the tert-butyl moiety of DL76. In silico data coincide with the results of experiments conducted in vitro. It was confirmed that Cunninghamella fungi are a very good model to study the metabolism of xenobiotics. The computational methods and microbial models of metabolism can be used as useful tools in early ADME-Tox assays in the process of developing new drug candidates.
    [Show full text]
  • Biotransformation of Natural Antioxidants Osajin and Pomiferin by Cunninghamella Elegans (ATCC® 9245TM)
    University of the Incarnate Word The Athenaeum Theses & Dissertations 5-2019 Biotransformation of Natural Antioxidants Osajin and Pomiferin by Cunninghamella Elegans (ATCC® 9245TM) Stephen Luis University of the Incarnate Word, [email protected] Follow this and additional works at: https://athenaeum.uiw.edu/uiw_etds Part of the Biochemistry Commons, and the Biology Commons Recommended Citation Luis, Stephen, "Biotransformation of Natural Antioxidants Osajin and Pomiferin by Cunninghamella Elegans (ATCC® 9245TM)" (2019). Theses & Dissertations. 359. https://athenaeum.uiw.edu/uiw_etds/359 This Thesis is brought to you for free and open access by The Athenaeum. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of The Athenaeum. For more information, please contact [email protected]. BIOTRANSFORMATION OF NATURAL ANTIOXIDANTS OSAJIN AND POMIFERIN BY CUNNINHAMELLA ELEGANS (ATCC® 9245TM) by STEPHEN B. LUIS A THESIS Presented to the Faculty of the University of the Incarnate Word in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE UNIVERSITY OF THE INCARNATE WORD May 2019 ii ACKNOWLEDGMENTS I would like to begin by thanking my thesis committee Dr. Paulo Carvalho, associate professor of pharmaceutical sciences at the Feik School of Pharmacy, Dr.’s Christopher Pierce and Ana Vallor, associate professors of biology at the University of the Incarnate Word, and my advisor Dr. Russel Raymond. Over the past two years I have had the privilege of coming to these four individuals for both assistance and guidance. No matter the situation or time of day, these four displayed unwavering dedication to ensuring the successful completion of this project. I would also like to give a special thanks to my parents and my girlfriend for always supporting me in every way possible and instilling in me the sense to never give up, no matter how grim the circumstances are.
    [Show full text]
  • A Comparative Genomic Investigation of Niche Adaptation in Fungi”
    The Pennsylvania State University The Graduate School Huck Institute of the Life Sciences A COMPARATIVE GENOMIC INVESTIGATION OF NICHE ADAPTATION IN FUNGI A Dissertation in Integrative Biosciences by Venkatesh Moktali © 2013 Venkatesh Moktali Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy August 2013 ! The dissertation of Venkatesh Moktali was reviewed and approved* by the following: Seogchan Kang Professor of Plant Pathology and Environmental Microbiology Dissertation Advisor Chair of Committee David M. Geiser Professor of Plant Pathology and Environmental Microbiology Kateryna Makova Professor of Biology Anton Nekrutenko Associate Professor of Biochemistry and Molecular Biology Yu Zhang Associate Professor of Statistics Peter Hudson Department Head, Huck Institute of the Life Sciences *Signatures are on file in the Graduate School ! ! Abstract The Kingdom Fungi has a diverse array of members adapted to very disparate and the most hostile surroundings on earth: such as living plant and/or animal tissues, soil, aquatic environments, other microorganisms, dead animals, and exudates of plants, animals and even nuclear reactors. The ability of fungi to survive in these various niches is supported by the presence of key enzymes/proteins that can metabolize extraneous harmful factors. Characterization of the evolution of these key proteins gives us a glimpse at the molecular mechanisms underpinning adaptations in these organisms. Cytochrome P450 proteins (CYPs) are among the most diversified protein families, they are involved in a number of processed that are critical to fungi. I evaluated the evolution of Cytochrome P450 proteins (CYPs) in order to understand niche adaptation in fungi. Towards this goal, a previously developed database the fungal cytochrome P450 database (FCPD) was improved and several features were added in order to allow for systematic comparative genomic and phylogenomic analysis of CYPs from numerous fungal genomes.
    [Show full text]
  • Cloning of the Cytochrome P450 Reductase (Crtr) Gene and Its
    Cloning of the cytochrome p450 reductase (crtR) gene and its involvement in the astaxanthin biosynthesis of Xanthophyllomyces dendrorhous Jennifer Alcaíno, Salvador Barahona, Marisela Carmona, Carla Lozano, Andrés Marcoleta, Mauricio Niklitschek, Dionisia Sepúlveda, Marcelo Baeza and Víctor Cifuentes* Address: Departamento de Ciencias Ecológicas, Facultad de Ciencias, Universidad de Chile, Santiago, Chile Email: Jennifer Alcaíno - [email protected]; Salvador Barahona - [email protected]; Marisela Carmona - [email protected]; Carla Lozano - [email protected]; Andrés Marcoleta - [email protected]; Mauricio Niklitschek - [email protected]; Dionisia Sepúlveda - [email protected]; Marcelo Baeza - [email protected]; Víctor Cifuentes* - [email protected] * Corresponding author Abstract Background: The yeast Xanthophyllomyces dendrorhous synthesizes astaxanthin, a carotenoid with high commercial interest. The proposed biosynthetic route in this organism is isopentenyl- pyrophosphate (IPP) → geranyleranyl pyrophosphate (GGPP) → phytoene → lycopene → β- carotene → astaxanthin. Recently, it has been published that the conversion of β-carotene into astaxanthin requires only one enzyme, astaxanthin synthase or CrtS, encoded by crtS gene. This enzyme belongs to the cytochrome P450 protein family. Results: In this work, a crtR gene was isolated from X. dendrorhous yeast, which encodes a cytochrome P450 reductase (CPR) that provides CrtS with the necessary electrons for substrate oxygenation. We determined the structural organization of the crtR gene and its location in the yeast electrophoretic karyotype. Two transformants, CBSTr and T13, were obtained by deleting the crtR gene and inserting a hygromycin B resistance cassette. The carotenoid composition of the transformants was altered in relation to the wild type strain. CBSTr forms yellow colonies because it is unable to produce astaxanthin, hence accumulating β-carotene.
    [Show full text]
  • 1 Biotransformation of Flurbiprofen by Cunninghamella Species 1 Jessica Amadio, Katherine Gordon and Cormac D. Murphy* 2 3 Schoo
    1 Biotransformation of flurbiprofen by Cunninghamella species 2 Jessica Amadio, Katherine Gordon and Cormac D. Murphy* 3 4 School of Biomolecular and Biomedical Science, Centre for Synthesis and Chemical 5 Biology, Ardmore House, University College Dublin, Dublin 4, Ireland 6 7 *Corresponding author Fax: +353 (0)1 716 1183, Telephone: +353 (0)1 716 1311, email: 8 [email protected] 9 10 Abstract 11 The biotransformation of the fluorinated anti-inflammatory drug flurbiprofen was 12 investigated in Cunninghamella spp. Mono- and di-hydroxylated metabolites were detected 13 using gas chromatography-mass spectrometry and fluorine-19 nuclear magnetic resonance 14 spectroscopy, and the major metabolite 4’-hydroxyflurbiprofen was isolated by preparative 15 HPLC. C. elegans DSM 1908 and C. blakesleeana DSM 1906 also produced a phase II 16 (conjugated) metabolite, which was identified as the sulfated drug via deconjugation 17 experiments. 1 18 One of the objectives of the recent European Union legislation governing the testing and 19 evaluation of chemicals, REACH (Regulation, Evaluation, Authorisation and Restriction of 20 Chemicals), is to further reduce the need for animals in the testing process. Some 21 microorganisms, such as the zygomycete fungus Cunninghamella and actinomycetes 22 bacteria, have been shown to metabolise xenobiotic compounds in an analogous fashion to 23 mammals (3, 5, 11, 17). It was suggested over three decades ago that microorganisms had 24 potential as models of mammalian metabolism (16), although there are concerns about their 25 predictive value (8). Nevertheless, certain microorganisms can be applied to the generation 26 of useful quantities of drug metabolic intermediates (13), which is more desirable than 27 isolation of these compounds from dosed animals, and avoids the concerns often associated 28 with chemical synthesis, such as the use of toxic reagents, and harsh reaction conditions.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9.486,437 B2 Rogowski Et Al
    USOO94864-37B2 (12) United States Patent (10) Patent No.: US 9.486,437 B2 Rogowski et al. (45) Date of Patent: *Nov. 8, 2016 (54) METHODS OF USING LOW-DOSE DOXEPIN 5,858.412 A 1/1999 Staniforth et al. FOR THE IMPROVEMENT OF SLEEP 5,866,166 A 2f1999 Staniforth et al. 5.948,438 A 9, 1999 Staniforth et al. (71) Applicants: Pernix Sleep, Inc., Morristown, NJ 5,965,166 A 10, 1999 Hunter et al. (US); ProCom One, Inc., San Marcos, 6,103,219 A 8, 2000 Sherwood et al. TX (US) 6,106,865 A 8, 2000 Staniforth et al. 6,211,229 B1 4/2001 Kavey (72) Inventors: Roberta L. Rogowski, Rancho Santa 6,217,907 B1 4/2001 Hunter et al. Fe, CA (US); Susan E. Dubé, Carlsbad, 6,217.909 B1 4/2001 Sherwood et al. CA (US); Philip Jochelson, San Diego, 6,219,674 B1 4/2001 Classen CA (US); Neil B. Kavey, Chappaqua, 6,344,487 B1 2/2002 Kavey 6,358,533 B2 3/2002 Sherwood et al. NY (US) 6,391,337 B2 5, 2002 Hunter et al. (73) Assignees: Pernix Sleep, Inc., Morristown, NJ 6,395,303 B1 5, 2002 Staniforth et al. (US); ProCom One, Inc., San Marcos, 6,403,597 B1 6/2002 Wilson et al. 6,407,128 B1 6/2002 Scaife et al. TX (US) 6,471.994 B1 10/2002 Staniforth et al. 6,521,261 B2 2/2003 Sherwood et al. (*) Notice: Subject to any disclaimer, the term of this 6,584,472 B2 6/2003 Classen patent is extended or adjusted under 35 6,683,102 B2 1/2004 Scaife et al.
    [Show full text]
  • Biology, Systematics and Clinical Manifestations of Zygomycota Infections
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by IBB PAS Repository Biology, systematics and clinical manifestations of Zygomycota infections Anna Muszewska*1, Julia Pawlowska2 and Paweł Krzyściak3 1 Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawiskiego 5a, 02-106 Warsaw, Poland; [email protected], [email protected], tel.: +48 22 659 70 72, +48 22 592 57 61, fax: +48 22 592 21 90 2 Department of Plant Systematics and Geography, University of Warsaw, Al. Ujazdowskie 4, 00-478 Warsaw, Poland 3 Department of Mycology Chair of Microbiology Jagiellonian University Medical College 18 Czysta Str, PL 31-121 Krakow, Poland * to whom correspondence should be addressed Abstract Fungi cause opportunistic, nosocomial, and community-acquired infections. Among fungal infections (mycoses) zygomycoses are exceptionally severe with mortality rate exceeding 50%. Immunocompromised hosts, transplant recipients, diabetic patients with uncontrolled keto-acidosis, high iron serum levels are at risk. Zygomycota are capable of infecting hosts immune to other filamentous fungi. The infection follows often a progressive pattern, with angioinvasion and metastases. Moreover, current antifungal therapy has often an unfavorable outcome. Zygomycota are resistant to some of the routinely used antifungals among them azoles (except posaconazole) and echinocandins. The typical treatment consists of surgical debridement of the infected tissues accompanied with amphotericin B administration. The latter has strong nephrotoxic side effects which make it not suitable for prophylaxis. Delayed administration of amphotericin and excision of mycelium containing tissues worsens survival prognoses. More than 30 species of Zygomycota are involved in human infections, among them Mucorales are the most abundant.
    [Show full text]
  • Mucormycosis: Botanical Insights Into the Major Causative Agents
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 8 June 2021 doi:10.20944/preprints202106.0218.v1 Mucormycosis: Botanical Insights Into The Major Causative Agents Naser A. Anjum Department of Botany, Aligarh Muslim University, Aligarh-202002 (India). e-mail: [email protected]; [email protected]; [email protected] SCOPUS Author ID: 23097123400 https://www.scopus.com/authid/detail.uri?authorId=23097123400 © 2021 by the author(s). Distributed under a Creative Commons CC BY license. Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 8 June 2021 doi:10.20944/preprints202106.0218.v1 Abstract Mucormycosis (previously called zygomycosis or phycomycosis), an aggressive, liFe-threatening infection is further aggravating the human health-impact of the devastating COVID-19 pandemic. Additionally, a great deal of mostly misleading discussion is Focused also on the aggravation of the COVID-19 accrued impacts due to the white and yellow Fungal diseases. In addition to the knowledge of important risk factors, modes of spread, pathogenesis and host deFences, a critical discussion on the botanical insights into the main causative agents of mucormycosis in the current context is very imperative. Given above, in this paper: (i) general background of the mucormycosis and COVID-19 is briefly presented; (ii) overview oF Fungi is presented, the major beneficial and harmFul fungi are highlighted; and also the major ways of Fungal infections such as mycosis, mycotoxicosis, and mycetismus are enlightened; (iii) the major causative agents of mucormycosis
    [Show full text]
  • Cunninghamella As a Microbiological Model for Metabolism of Histamine H3 Receptor Antagonist 1-[3-(4-Tert-Butylphenoxy)Propyl]Piperidine
    Appl Biochem Biotechnol DOI 10.1007/s12010-012-9880-8 Cunninghamella as a Microbiological Model for Metabolism of Histamine H3 Receptor Antagonist 1-[3-(4-tert-Butylphenoxy)propyl]piperidine Elżbieta Pękala & Paulina Kubowicz & Dorota Łażewska Received: 5 March 2012 /Accepted: 28 August 2012 # The Author(s) 2012. This article is published with open access at Springerlink.com Abstract The aim of the study was to analyze the ability of the microorganism Cunninghamella to carry out the biotransformation of 1-[3-(4-tert-butylphenoxy)- propyl]piperidine (DL76) and to compare the obtained results with in silico models. Biotransformation was carried out by three strains of filamentous fungus: Cunning- hamella echinulata, Cunninghamella blakesleeana,andCunninghamella elegans. Most probable direction of DL76 metabolic transition was the oxidation of the methyl group in the tert-butyl moiety leading to the formation of the metabolite with I° alcohol properties. This kind of reaction was conducted by all three strains tested. However, only in the case of C. blakesleeana that biotransformation product had a structure of carboxylic acid. CYP2C19 was identified by Metasite software to be the isoform of major importance in the oxidation process in the tert-butyl moiety of DL76. In silico data coincide with the results of experiments conducted in vitro. It was confirmed that Cunninghamella fungi are a very good model to study the metabolism of xenobiotics. The computational methods and microbial models of metabolism can be used as useful tools in early ADME-Tox assays in the process of developing new drug candidates. Keywords Cunninghamella . Biotransformation . Microbiological model . In vitro metabolism . In silico metabolism Introduction Each drug before it is introduced to the market must undergo a complicated procedure.
    [Show full text]
  • Identification of Fungal Community Associated with Deterioration of Optical Observation Instruments of Museums in Northern Vietn
    applied sciences Article Identification of Fungal Community Associated with Deterioration of Optical Observation Instruments of Museums in Northern Vietnam Cao Cuong Ngo 1,2,†, Quang Huy Nguyen 3,† , Thu Hoai Nguyen 2, Ngoc Tung Quach 1,4, Pravin Dudhagara 5, Thi Hanh Nguyen Vu 1,4, Thi Thanh Xuan Le 1, Thi Thu Hang Le 3, Thi Thu Hong Do 2, Van Duc Nguyen 6, Nam Trung Nguyen 1,4 and Quyet-Tien Phi 1,4,* 1 Institute of Biotechnology, Vietnam Academy of Science and Technology, Hanoi 100000, Vietnam; [email protected] (C.C.N.); [email protected] (N.T.Q.); [email protected] (T.H.N.V.); [email protected] (T.T.X.L.); [email protected] (N.T.N.) 2 Vietnam-Russia Tropical Centre, Hanoi 100000, Vietnam; [email protected] (T.H.N.); [email protected] (T.T.H.D.) 3 LMI DRISA, Department of Life Sciences, University of Science and Technology of Hanoi, Vietnam Academy of Science and Technology, Hanoi 100000, Vietnam; [email protected] (Q.H.N.); [email protected] (T.T.H.L.) 4 Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi 100000, Vietnam 5 Department of Biosciences (UGC-SAP-II & DST-FIST-I), Veer Narmad South Gujarat University, Surat 395007, India; [email protected] 6 General Department of Technology, Ministry of Defense, Hanoi 100000, Vietnam; [email protected] Citation: Ngo, C.C.; Nguyen, Q.H.; * Correspondence: [email protected] or [email protected] Nguyen, T.H.; Quach, N.T.; † These authors have contributed equally to this work and share the first authorship.
    [Show full text]